IMERYS and Omya entered into exclusive negotiations to form a technology Joint Venture

IMERYS and Omya entered into exclusive negotiations to form a technology Joint Venture


IMERYS S.A. and Omya AG are pleased to announce they have entered into exclusive negotiations to form a 50:50 technology Joint Venture to promote the research and development of Microfibrillated Cellulose (MFC) concerning a variety of applications and industries. The venture will combine the FiberLean™ and Omya’s MFC technology platforms developed by each company into one entity, henceforth to be known as FiberLean™ Technologies.

The first commercial product available, which has already been granted a Food Contact Notification (FCN) by the US Food and Drug Administration, allows paper & packaging producers to improve quality and/or increase the mineral filler loading to achieve productivity gains and reduced costs.

The commercialization of MFC is to be independently and separately undertaken by IMERYS and Omya commercial teams making the technology easily accessible to customers across various industries.

Micro and Nano Cellulosics are renewable, sustainable engineered materials with the potential to deliver exceptional performance and value to a wide range of industrial and consumer markets. FiberLean™ Technologies will expand its process and application technology to deliver such products and solutions.

The world leader in mineral-based specialty solutions for industry, with €4.1 billion revenue and 16,300 employees in 2015, Imerys transforms a unique range of minerals to deliver essential functions (heat resistance, mechanical strength, conductivity, coverage, barrier effect, etc.) that are essential to its customers’ products and manufacturing processes.

Whether mineral components, functional additives, process enablers or finished products, Imerys’ solutions contribute to the quality of a great number of applications in consumer goods, industrial equipment or construction. Combining expertise, creativity and attentiveness to customers’ needs, the Group’s international teams constantly identify new applications and develop high value-added solutions under a determined approach to responsible development. These strengths enable Imerys to develop through a sound, profitable business model.

More comprehensive information about Imerys may be obtained from its website ( under Regulated Information, particularly in its 2014 Registration Document filed with the Autorité des marchés financiers on March 19, 2015 under number D.15-0173 (also available from the Autorité des marchés financiers website, Imerys draws the attention of investors to chapter 4, “Risk Factors and Internal Control”, of its Registration Document.

Analyst/Investor relations:
Vincent Gouley – + 33 (0)1 49 55 64 69
Press contacts:
Vincent Gouley – + 33 (0)1 49 55 64 69
Philémon Tassel – + 33 (0)6 30 10 96 11
Sarah Fornier – + 33 (0)7 87 40 83 50